LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tumors Require Help from Macrophages to Metastasize

By LabMedica International staff writers
Posted on 25 Aug 2009
Cancer researchers have found that metastasis relies on the cooperation of a distinct sub-population of macrophages, a link that may be broken by appropriate drug intervention.

Investigators at the Albert Einstein College of Medicine (New York, NY, USA) analyzed the movement of breast cancer cells in mice. They reported in the August 10, 2009, online edition of the journal PLoS ONE that a population of host macrophages displaying a distinct phenotype was recruited by roaming pulmonary metastatic cells regardless of species of origin.

Reduction of this macrophage population through three independent means (genetic and chemical) showed that these macrophages were required for efficient metastatic seeding and growth. Importantly, even after metastatic growth was established, elimination of this macrophage population inhibited subsequent growth.

"This new study is important because it definitively shows the effects of macrophages at distant sites, as well as the identity of the macrophage population," explained senior author Dr. Jeffrey W. Pollard, professor of developmental and molecular biology at Albert Einstein College of Medicine. "This is the first proof that they have impact at this location, at the site of metastatic tumor growth."

"This suggests that antimacrophage therapy will have an impact in patients even with metastatic disease," said Dr. Pollard. "Macrophages themselves, or their unique signaling pathways, represent new therapeutic targets that may be efficacious in reducing cancer mortality."

Related Links:

Albert Einstein College of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
25 Aug 2009  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
25 Aug 2009  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
25 Aug 2009  |   BioResearch